Journal article
S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: Efficacy and effects of histamine and carnitine as moderators of response
J Sarris, G I. Papakostas, O Vitolo, M Fava, D Mischoulon
Journal of Affective Disorders | ELSEVIER | Published : 2014
Abstract
Objective To assess the antidepressant efficacy of S-adenosyl methionine (SAMe), a naturally occurring methyl donor, versus the selective serotonin reuptake inhibitor (SSRI) escitalopram and a placebo control; and to determine whether serum histamine or carnitine levels modified treatment response. Methods We examined a subsample (n=144) from one site of a two-site study of adults with diagnosed Major Depressive Disorder (MDD), recruited from 4/13/05 to 12/22/09, who consented to the additional blood draw for serum histamine and carnitine levels. After washout, eligible subjects were randomized to SAMe (1600-3200 mg/daily), escitalopram (10-20 mg/daily), or matching placebo for 12 weeks of d..
View full abstractRelated Projects (1)
Grants
Awarded by National Institutes of Health
Funding Acknowledgements
The parent study was supported by Grant R01AT001638-01A1 to Dr. Maurizio Fava, from the National Institutes of Health (NIH) and the National Center for Complementary and Alternative Medicine (NCCAM).Dr. Jerome Sarris was funded by a CR Roper Fellowship.Dr. David Mischoulon was funded by a Grant from the Bowman Family Foundation.